Skip to content
2000
image of Validation of the Zwolle Risk Score in STEMI Patients Undergoing Primary PCI: Insights from the 
ISCAS-STEMI COVID-19 Registry

Abstract

Background

Several scores have been developed to facilitate risk stratification and early discharge following primary angioplasty, particularly the Zwolle Risk Score (ZRS). However, validation in large-sized studies is still lacking. Therefore, the aim of the current study was to validate the use of the ZRS in a contemporary global population, including patients who were treated during the SARS-CoV-2 pandemic and enrolled in a large intercontinental observational study.

Methods

The ISACS-STEMI COVID-19 is a large-scale retrospective multicenter registry involving primary PCI centers from Europe, Latin America, South-East Asia, and NorthAfrica, including patients treated from March 1st until June 30th, in 2019 and 2020]. ZRS was calculated for each patient. The patients were additionally categorized according to the following values of the ZRS [≤3; 4-6; 7-9; ≥10]. Our study outcomes were in-hospital and 30-day mortality. The discriminatory capacity of the ZRS was assessed by the area under the ROC curve [ statistic] as an index of model performance.

Results

Our population is represented by 16084 STEMI patients undergoing mechanical reperfusion enrolled in 109 centers. The score showed a very good performance in the predicting mortality both in-hospital [AUC=0.83 [0.82-0.85], p<0.0001] and at 30-day follow-up [AUC=0.82 [0.81-0.84, p<0.0001]. The results were confirmed when the ZRS was separately applied to patients treated in 2019 and 2020, with good stability across time. ZRS was able to identify a large cohort [n=10672, 66.3%] of low-risk patients [score ≤3] with a very low mortality rate at 2 days [1%] and between 3 and 10 days [0.7%], with a very good negative predictive value for in-hospital [98.3%] and 30-day mortality [97.7%], with similar results in 2019 and 2020.

Conclusion

This study is the first to demonstrate the good prognostic performance of the ZRS in a large-scale contemporary global multicenter validation set. Similar results were obtained both in the pre-pandemic and the COVID-19 era. ZRS ≤3 identified a very low-risk population that could be discharged early, even during the COVID-19 pandemic, with expected advantages in the availability of hospital beds and nursing staff, costs of medical care, and in-hospital risk of contagion.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cvp/10.2174/0115701611335913250408214530
2025-04-16
2025-11-13

  • From This Site

    /content/journals/cvp/10.2174/0115701611335913250408214530
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. Ibanez B. James S. Agewall S. Antunes M.J. Bucciarelli-Ducci C. Bueno H. Caforio A.L.P. Crea F. Goudevenos J.A. Halvorsen S. Hindricks G. Kastrati A. Lenzen M.J. Prescott E. Roffi M. Valgimigli M. Varenhorst C. Vranckx P. Widimský P. Collet J-P. Kristensen S.D. Aboyans V. Baumbach A. Bugiardini R. Coman I.M. Delgado V. Fitzsimons D. Gaemperli O. Gershlick A.H. Gielen S. Harjola V-P. Katus H.A. Knuuti J. Kolh P. Leclercq C. Lip G.Y.H. Morais J. Neskovic A.N. Neumann F-J. Niessner A. Piepoli M.F. Richter D.J. Shlyakhto E. Simpson I.A. Steg P.G. Terkelsen C.J. Thygesen K. Windecker S. Zamorano J.L. Zeymer U. Windecker S. Aboyans V. Agewall S. Barbato E. Bueno H. Coca A. Collet J-P. Coman I.M. Dean V. Delgado V. Fitzsimons D. Gaemperli O. Hindricks G. Iung B. Jüni P. Katus H.A. Knuuti J. Lancellotti P. Leclercq C. McDonagh T. Piepoli M.F. Ponikowski P. Richter D.J. Roffi M. Shlyakhto E. Simpson I.A. Zamorano J.L. Chettibi M. Hayrapetyan H.G. Metzler B. Ibrahimov F. Sujayeva V. Beauloye C. Dizdarevic-Hudic L. Karamfiloff K. Skoric B. Antoniades L. Tousek P. Terkelsen P.C.J. Shaheen S.M. Marandi T. Niemelä M. Kedev S. Gilard M. Aladashvili A. Elsaesser A. Kanakakis I.G. Merkely B. Gudnason T. Iakobishvili Z. Bolognese L. Berkinbayev S. Bajraktari G. Beishenkulov M. Zake I. Lamin H.B. Gustiene O. Pereira B. Xuereb R.G. Ztot S. Juliebø V. Legutko J. Timóteo A.T. Tatu-Chiţoiu G. Yakovlev A. Bertelli L. Nedeljkovic M. Studenčan M. Bunc M. García de Castro A.M. Petursson P. Jeger R. Mourali M.S. Yildirir A. Parkhomenko A. Gale C.P. ESC Scientific Document Group 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur. Heart J. 2018 39 2 119 177 10.1093/eurheartj/ehx393 28886621
    [Google Scholar]
  2. De Luca G. Dirksen M.T. Spaulding C. Kelbæk H. Schalij M. Thuesen L. van der Hoeven B. Vink M.A. Kaiser C. Musto C. Chechi T. Spaziani G. Diaz de la Llera L.S. Pasceri V. Di Lorenzo E. Violini R. Suryapranata H. Stone G.W. DESERT cooperation Impact of diabetes on long-term outcome after primary angioplasty: Insights from the DESERT cooperation. Diabetes Care 2013 36 4 1020 1025 10.2337/dc12‑1507 23275351
    [Google Scholar]
  3. De Luca G. van ’t Hof A.W.J. Ottervanger J.P. Hoorntje J.C.A. Gosselink A.T.M. Dambrink J.H.E. de Boer M.J. Suryapranata H. Ageing, impaired myocardial perfusion, and mortality in patients with ST-segment elevation myocardial infarction treated by primary angioplasty. Eur. Heart J. 2005 26 7 662 666 10.1093/eurheartj/ehi110 15681574
    [Google Scholar]
  4. Sorajja P. Gersh B.J. Cox D.A. McLaughlin M.G. Zimetbaum P. Costantini C. Stuckey T. Tcheng J.E. Mehran R. Lansky A.J. Grines C.L. Stone G.W. Impact of multivessel disease on reperfusion success and clinical outcomes in patients undergoing primary percutaneous coronary intervention for acute myocardial infarction. Eur. Heart J. 2007 28 14 1709 1716 10.1093/eurheartj/ehm184 17556348
    [Google Scholar]
  5. De Luca G. Suryapranata H. Dambrink J.H. Ottervanger J.P. van’t Hof A.W.J. Zijlstra F. Hoorntje J.C.A. Gosselink A.T.M. de Boer M.J. Sex-related differences in outcome after ST-segment elevation myocardial infarction treated by primary angioplasty: Data from the Zwolle Myocardial Infarction study. Am. Heart J. 2004 148 5 852 856 10.1016/j.ahj.2004.05.018 15523317
    [Google Scholar]
  6. De Luca G. van’t Hof A.W.J. de Boer M.J. Hoorntje J.C.A. Gosselink A.T.M. Dambrink J.H.E. Ottervanger J.P. Zijlstra F. Suryapranata H. Impaired myocardial perfusion is a major explanation of the poor outcome observed in patients undergoing primary angioplasty for ST-segment-elevation myocardial infarction and signs of heart failure. Circulation 2004 109 8 958 961 10.1161/01.CIR.0000120504.31457.28 14981008
    [Google Scholar]
  7. Morrow D.A. Antman E.M. Charlesworth A. Cairns R. Murphy S.A. de Lemos J.A. Giugliano R.P. McCabe C.H. Braunwald E. TIMI risk score for ST-elevation myocardial infarction: A convenient, bedside, clinical score for risk assessment at presentation: An intravenous nPA for treatment of infarcting myocardium early II trial substudy. Circulation 2000 102 17 2031 2037 10.1161/01.CIR.102.17.2031 11044416
    [Google Scholar]
  8. Jacobs D.R. Jr Kroenke C. Crow R. Deshpande M. Gu D.F. Gatewood L. Blackburn H. PREDICT: A simple risk score for clinical severity and long-term prognosis after hospitalization for acute myocardial infarction or unstable angina: The Minnesota heart survey. Circulation 1999 100 6 599 607 10.1161/01.CIR.100.6.599 10441096
    [Google Scholar]
  9. Grines C.L. Marsalese D.L. Brodie B. Griffin J. Donohue B. Costantini C.R. Balestrini C. Stone G. Wharton T. Esente P. Spain M. Moses J. Nobuyoshi M. Ayres M. Jones D. Mason D. Sachs D. Grines L.L. O’Neill W. Safety and cost-effectiveness of early discharge after primary angioplasty in low risk patients with acute myocardial infarction. PAMI-II investigators. Primary Angioplasty in Myocardial Infarction. J. Am. Coll. Cardiol. 1998 31 5 967 972 10.1016/S0735‑1097(98)00031‑X 9561995
    [Google Scholar]
  10. Kandzari D.E. Tcheng J.E. Cohen D.J. Bakhai A. Grines C.L. Cox D.A. Effron M. Stuckey T. Griffin J.J. Turco M. Carroll J.D. Fahy M. Mehran R. Stone G.W. CADILLAC Investigators Feasibility and implications of an early discharge strategy after percutaneous intervention with abciximab in acute myocardial infarction (the CADILLAC Trial). Am. J. Cardiol. 2003 92 7 779 784 10.1016/S0002‑9149(03)00882‑8 14516875
    [Google Scholar]
  11. Granger C.B. Goldberg R.J. Dabbous O. Pieper K.S. Eagle K.A. Cannon C.P. Van De Werf F. Avezum A. Goodman S.G. Flather M.D. Fox K.A. Global Registry of Acute Coronary Events Investigators Predictors of hospital mortality in the global registry of acute coronary events. Arch. Intern. Med. 2003 163 19 2345 2353 10.1001/archinte.163.19.2345 14581255
    [Google Scholar]
  12. De Luca G. Suryapranata H. van’t Hof A.W.J. de Boer M.J. Hoorntje J.C.A. Dambrink J.H.E. Gosselink A.T.M. Ottervanger J.P. Zijlstra F. Prognostic assessment of patients with acute myocardial infarction treated with primary angioplasty: Implications for early discharge. Circulation 2004 109 22 2737 2743 10.1161/01.CIR.0000131765.73959.87 15159293
    [Google Scholar]
  13. Lim T.W. Karim T.S. Fernando M. Haydar J. Lightowler R. Yip B. Sriamareswaran R. Tong D.C. Layland J. Utility of Zwolle risk score in guiding low-risk STEMI discharge. Heart Lung Circ. 2021 30 4 489 495 10.1016/j.hlc.2020.08.026 33277179
    [Google Scholar]
  14. Ebinger J.E. Strauss C.E. Garberich R.R. Bradley S.M. Rush P. Chavez I.J. Poulose A.K. Porten B.R. Henry T.D. Value-based ST-segment–elevation myocardial infarction care using risk-guided triage and early discharge. Circ. Cardiovasc. Qual. Outcomes 2018 11 4 e004553 10.1161/CIRCOUTCOMES.118.004553 29654000
    [Google Scholar]
  15. Tralhão A. Ferreira A.M. Madeira S. Borges Santos M. Castro M. Rosário I. Trabulo M. Aguiar C. Ferreira J. Almeida M.S. Mendes M. Applicability of the Zwolle risk score for safe early discharge after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction. Rev. Port. Cardiol. 2015 34 9 535 541 10.1016/j.repc.2015.04.006 26297630
    [Google Scholar]
  16. Littnerova S. Kala P. Jarkovsky J. Kubkova L. Prymusova K. Kubena P. Tesak M. Toman O. Poloczek M. Spinar J. Dusek L. Parenica J. GRACE score among six risk scoring systems (CADILLAC, PAMI, TIMI, Dynamic TIMI, Zwolle) demonstrated the best predictive value for prediction of long-term mortality in patients with st-elevation myocardial infarction. PLoS One 2015 10 4 e0123215 10.1371/journal.pone.0123215 25893501
    [Google Scholar]
  17. Banga S. Gumm D.C. Kizhakekuttu T.J. Emani V.K. Singh S. Singh S. Kaur H. Wang Y. Mungee S. Left ventricular ejection fraction along with zwolle risk score for risk stratification to enhance safe and early discharge in stemi patients undergoing primary percutaneous coronary intervention: A retrospective observational study. Cureus 2019 11 7 e5272 10.7759/cureus.5272 31583196
    [Google Scholar]
  18. Ali Shah J. Ahmed Solangi B. Batra M.K. Khan K.A. Shah G.A. Ali G. Zehra M. Hassan M. Zubair M. Karim M. Zwolle risk score for safety assessment of same-day discharge after primary Percutaneous coronary intervention. J. Saudi Heart Assoc. 2021 33 4 332 338 10.37616/2212‑5043.1283 35083125
    [Google Scholar]
  19. Ganovska E. Arrigo M. Helanova K. Littnerova S. Sadoune M. Kubena P. Pavlusova M. Jarkovsky J. Gottwaldova J. Kala P. Dastych M. Ishihara S. Van Aelst L.N.L. Cohen-Solal A. Gayat E. Spinar J. Parenica J. Mebazaa A. GREAT Network Natriuretic peptides in addition to Zwolle score to enhance safe and early discharge after acute myocardial infarction: A prospective observational cohort study. Int. J. Cardiol. 2016 215 527 531 10.1016/j.ijcard.2016.04.148 27155548
    [Google Scholar]
  20. Azzalini L. Solé E. Sans J. Vila M. Durán A. Gil-Alonso D. Santaló M. Garcia-Moll X. Sionis A. Feasibility and safety of an early discharge strategy after low-risk acute myocardial infarction treated with primary percutaneous coronary intervention: The EDAMI pilot trial. Cardiology 2015 130 2 120 129 10.1159/000368890 25612789
    [Google Scholar]
  21. Schellings D.A.A.M. Adiyaman A. Giannitsis E. Hamm C. Suryapranata H. ten Berg J.M. Hoorntje J.C.A. van’t Hof A.W.J. Early discharge after primary percutaneous coronary intervention: The added value of N-terminal pro-brain natriuretic peptide to the Zwolle Risk Score. J. Am. Heart Assoc. 2014 3 6 e001089 10.1161/JAHA.114.001089 25389283
    [Google Scholar]
  22. Abelin A.P. David R.B. Gottschall C.A. Quadros A.S. Accuracy of dedicated risk scores in patients undergoing primary percutaneous coronary intervention in daily clinical practice. Can. J. Cardiol. 2014 30 1 125 131 10.1016/j.cjca.2013.07.673 24238848
    [Google Scholar]
  23. Parr C.J. Avery L. Hiebert B. Liu S. Minhas K. Ducas J. Using the Zwolle risk score at time of coronary angiography to triage patients with st‐elevation myocardial infarction following primary Percutaneous coronary intervention or thrombolysis. J. Am. Heart Assoc. 2022 11 4 e024759 10.1161/JAHA.121.024759 35132867
    [Google Scholar]
  24. González A.R. Hameau D.R. Alvarado L.C. Hameau D.C. Pérez P.F. Olmos C.A. Pérez P.O. Implementation of an early discharge protocol in patients with ST-segment elevation myocardial infarction. Rev. Med. Chil. 2024 152 3 314 321 10.4067/s0034‑98872024000300314 39450835
    [Google Scholar]
  25. Shah J.A. Kumar R. Solangi B.A. Khan K.A. Ahmed T. Khowaja S. Ali G. Zehra M. Sial J.A. Karim M. Saghir T. Qamar N. One-year major adverse cardiovascular events among same-day discharged patients after primary percutaneous coronary intervention at a tertiary care cardiac centre in Karachi, Pakistan: A prospective observational study. BMJ Open 2023 13 4 e067971 10.1136/bmjopen‑2022‑067971 37037620
    [Google Scholar]
  26. Kotowycz M.A. Cosman T.L. Tartaglia C. Afzal R. Syal R.P. Natarajan M.K. Safety and feasibility of early hospital discharge in ST-segment elevation myocardial infarction—A prospective and randomized trial in low-risk primary percutaneous coronary intervention patients (the Safe-Depart Trial). Am. Heart J. 2010 159 1 117.e1 117.e6 10.1016/j.ahj.2009.10.024 20102876
    [Google Scholar]
  27. Kozieradzka A. Kamiński K.A. Maciorkowska D. Olszewska M. Dobrzycki S. Nowak K. Kralisz P. Prokopczuk P. Musial W.J. GRACE, TIMI, Zwolle and CADILLAC risk scores — Do they predict 5-year outcomes after ST-elevation myocardial infarction treated invasively? Int. J. Cardiol. 2011 148 1 70 75 10.1016/j.ijcard.2009.10.026 19923016
    [Google Scholar]
  28. Kotowycz M.A. Pal Syal R. Afzal R. Natarajan M.K. Can we improve length of hospitalization in ST elevation myocardial infarction patients treated with primary percutaneous coronary intervention? Can. J. Cardiol. 2009 25 10 585 588 10.1016/S0828‑282X(09)70717‑2 19812804
    [Google Scholar]
  29. De Luca G. Verdoia M. Cercek M. Jensen L.O. Vavlukis M. Calmac L. Johnson T. Ferrer G.R. Ganyukov V. Wojakowski W. Kinnaird T. van Birgelen C. Cottin Y. IJsselmuiden A. Tuccillo B. Versaci F. Royaards K.J. Berg J.T. Laine M. Dirksen M. Siviglia M. Casella G. Kala P. Díez Gil J.L. Banning A. Becerra V. De Simone C. Santucci A. Carrillo X. Scoccia A. Amoroso G. Lux A. Kovarnik T. Davlouros P. Mehilli J. Gabrielli G. Rios X.F. Bakraceski N. Levesque S. Cirrincione G. Guiducci V. Kidawa M. Spedicato L. Marinucci L. Ludman P. Zilio F. Galasso G. Fabris E. Menichelli M. Garcia-Touchard A. Manzo S. Caiazzo G. Moreu J. Forés J.S. Donazzan L. Vignali L. Teles R. Benit E. Agostoni P. Bosa Ojeda F. Lehtola H. Camacho-Freiere S. Kraaijeveld A. Antti Y. Boccalatte M. Deharo P. Martínez-Luengas I.L. Scheller B. Alexopoulos D. Moreno R. Kedhi E. Uccello G. Faurie B. Gutierrez Barrios A. Di Uccio F.S. Wilbert B. Smits P. Cortese G. Parodi G. Dudek D. Impact of covid-19 pandemic on mechanical reperfusion for patients with STEMI. J. Am. Coll. Cardiol. 2020 76 20 2321 2330 10.1016/j.jacc.2020.09.546 33183506
    [Google Scholar]
  30. De Luca G. Cercek M. Jensen L.O. Vavlukis M. Calmac L. Johnson T. Roura i Ferrer G. Ganyukov V. Wojakowski W. von Birgelen C. Versaci F. Ten Berg J. Laine M. Dirksen M. Casella G. Kala P. Díez Gil J.L. Becerra V. De Simone C. Carrill X. Scoccia A. Lux A. Kovarnik T. Davlouros P. Gabrielli G. Flores Rios X. Bakraceski N. Levesque S. Guiducci V. Kidawa M. Marinucci L. Zilio F. Galasso G. Fabris E. Menichelli M. Manzo S. Caiazzo G. Moreu J. Sanchis Forés J. Donazzan L. Vignali L. Teles R. Bosa Ojeda F. Lehtola H. Camacho-Freiere S. Kraaijeveld A. Antti Y. Boccalatte M. Martínez-Luengas I.L. Scheller B. Alexopoulos D. Uccello G. Faurie B. Gutierrez Barrios A. Wilbert B. Cortese G. Moreno R. Parodi G. Kedhi E. Verdoia M. Impact of COVID-19 pandemic and diabetes on mechanical reperfusion in patients with STEMI: Insights from the ISACS STEMI covid 19 registry. Cardiovasc. Diabetol. 2020 19 1 215 10.1186/s12933‑020‑01196‑0 33339541
    [Google Scholar]
  31. Xiang D. Xiang X. Zhang W. Yi S. Zhang J. Gu X. Xu Y. Huang K. Su X. Yu B. Wang Y. Fang W. Huo Y. Ge J. Management and outcomes of patients with STEMI during the covid-19 pandemic in China. J. Am. Coll. Cardiol. 2020 76 11 1318 1324 10.1016/j.jacc.2020.06.039 32828614
    [Google Scholar]
  32. De Luca G. Silverio A. Verdoia M. Siudak Z. Tokarek T. Kite T.A. Gershlick A.H. Rodriguez-Leor O. Cid-Alvarez B. Jones D.A. Rathod K.S. Montero-Cabezas J.M. Jurado-Roman A. Nardin M. Galasso G. Angiographic and clinical outcome of SARS-CoV-2 positive patients with ST-segment elevation myocardial infarction undergoing primary angioplasty: A collaborative, individual patient data meta-analysis of six registry-based studies. Eur. J. Intern. Med. 2022 105 69 76 10.1016/j.ejim.2022.08.021 35999094
    [Google Scholar]
  33. De Luca G. Suryapranata H. Ottervanger J.P. Antman E.M. Time delay to treatment and mortality in primary angioplasty for acute myocardial infarction: Every minute of delay counts. Circulation 2004 109 10 1223 1225 10.1161/01.CIR.0000121424.76486.20 15007008
    [Google Scholar]
  34. Deluca G. van ’t Hof A.W. de Boer M.J. Ottervanger J.P. Hoorntje J.C. Gosselink A.T. Dambrink J.H. Zijlstra F. Suryapranata H. Time-to-treatment significantly affects the extent of ST-segment resolution and myocardial blush in patients with acute myocardial infarction treated by primary angioplasty. Eur. Heart J. 2004 25 12 1009 1013 10.1016/j.ehj.2004.03.021 15191770
    [Google Scholar]
  35. De Luca G. Smits P. Hofma S.H. Di Lorenzo E. Vlachojannis G.J. van’t Hof A.W.J. van Boven A.J. Kedhi E. Stone G.W. Suryapranata H. Drug-Eluting Stent in Primary Angioplasty (DESERT 3) cooperation Everolimus eluting stent vs first generation drug-eluting stent in primary angioplasty: A pooled patient-level meta-analysis of randomized trials. Int. J. Cardiol. 2017 244 121 127 10.1016/j.ijcard.2017.06.022 28673736
    [Google Scholar]
  36. Costa F. Montalto C. Branca M. Hong S.J. Watanabe H. Franzone A. Vranckx P. Hahn J.Y. Gwon H.C. Feres F. Jang Y. De Luca G. Kedhi E. Cao D. Steg P.G. Bhatt D.L. Stone G.W. Micari A. Windecker S. Kimura T. Hong M.K. Mehran R. Valgimigli M. Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: A meta-analysis of randomized trials. Eur. Heart J. 2023 44 11 954 968 10.1093/eurheartj/ehac706 36477292
    [Google Scholar]
  37. Verdoia M. Schaffer A. Barbieri L. Cassetti E. Piccolo R. Galasso G. Marino P. Sinigaglia F. De Luca G. Benefits from new ADP antagonists as compared with clopidogrel in patients with stable angina or acute coronary syndrome undergoing invasive management: A meta-analysis of randomized trials. J. Cardiovasc. Pharmacol. 2014 63 4 339 350 10.1097/FJC.0000000000000052 24336016
    [Google Scholar]
  38. De Luca G. Schaffer A. Wirianta J. Suryapranata H. Comprehensive meta-analysis of radial vs femoral approach in primary angioplasty for STEMI. Int. J. Cardiol. 2013 168 3 2070 2081 10.1016/j.ijcard.2013.01.161 23490083
    [Google Scholar]
  39. Tokarek T. Dziewierz A. Plens K. Rakowski T. Dudek D. Siudak Z. Radial approach reduces mortality in patients with ST-segment elevation myocardial infarction and cardiogenic shock. Pol Arch Intern Med. 2021 131 5 421 428 33739779
    [Google Scholar]
  40. De Luca G. Navarese E.P. Suryapranata H. A meta-analytic overview of thrombectomy during primary angioplasty. Int. J. Cardiol. 2013 166 3 606 612 10.1016/j.ijcard.2011.11.102 22284272
    [Google Scholar]
  41. De Luca G. Navarese E.P. Cassetti E. Verdoia M. Suryapranata H. Meta-analysis of randomized trials of glycoprotein IIb/IIIa inhibitors in high-risk acute coronary syndromes patients undergoing invasive strategy. Am. J. Cardiol. 2011 107 2 198 203 10.1016/j.amjcard.2010.08.063 21211597
    [Google Scholar]
  42. Asad Z.U.A. Khan S.U. Amritphale A. Shroff A. Lata K. Seto A.H. Khan M.S. Rao S.V. Abu-Fadel M. Early vs late discharge in low-risk ST-elevation myocardial infarction patients treated with Percutaneous Coronary intervention: A systematic review and meta-analysis. Cardiovasc. Revasc. Med. 2020 21 11 1360 1368 10.1016/j.carrev.2020.04.030 32473910
    [Google Scholar]
/content/journals/cvp/10.2174/0115701611335913250408214530
Loading
Validation of the Zwolle Risk Score in STEMI Patients Undergoing Primary PCI: Insights from the 
ISCAS-STEMI COVID-19 Registry
Bentham Science Publishers ; https://doi.org/10.2174/0115701611335913250408214530
/content/journals/cvp/10.2174/0115701611335913250408214530
/content/journals/cvp/10.2174/0115701611335913250408214530
Loading

Data & Media loading...

Supplements

Supplementary material is available on the publisher's website along with the published article.

file format download Download

  • Article Type:     Research Article
Keywords: mechanical reperfusion ; Zwolle Risk Score ; STEMI patients ; pandemic ; COVID-19 registry

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test